336 related articles for article (PubMed ID: 2201437)
1. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
[TBL] [Abstract][Full Text] [Related]
2. Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice.
Schmeiser HH; Scherf HR; Wiessler M
Cancer Lett; 1991 Aug; 59(2):139-43. PubMed ID: 1884371
[TBL] [Abstract][Full Text] [Related]
3. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
Arlt VM; Wiessler M; Schmeiser HH
Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
[TBL] [Abstract][Full Text] [Related]
4. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
5. ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues.
Wang Y; Arlt VM; Roufosse CA; McKim KL; Myers MB; Phillips DH; Parsons BL
Environ Mol Mutagen; 2012 Aug; 53(7):495-504. PubMed ID: 22729866
[TBL] [Abstract][Full Text] [Related]
6. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
[TBL] [Abstract][Full Text] [Related]
7. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
8. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
9. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid.
Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH
Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074
[TBL] [Abstract][Full Text] [Related]
10. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
12. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
17. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
[TBL] [Abstract][Full Text] [Related]
18. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I.
Fernando RC; Schmeiser HH; Scherf HR; Wiessler M
IARC Sci Publ; 1993; (124):167-71. PubMed ID: 8225480
[TBL] [Abstract][Full Text] [Related]
19. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
20. Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide.
Ronai ZA; Gradia S; el-Bayoumy K; Amin S; Hecht SS
Carcinogenesis; 1994 Oct; 15(10):2113-6. PubMed ID: 7955041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]